Clinical trial VICTORIA-01
A multicenter, open-label, phase 1 study to evaluate the safety and preliminary efficacy of SOT201 in patients with advanced/metastatic solid tumors (SC201 / VICTORIA-01)
| Organ | Multiple |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Sotio |
| EudraCT Identifier | 2023-504330-21-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT06163391 |
| Last update |